Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.82
+0.01 (0.08%)
Feb 27, 2026, 3:04 PM CST

SHE:301211 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
5,3546,1236,2648,3169,026-
Market Cap Growth
7.45%-2.25%-24.68%-7.87%--
Enterprise Value
3,7864,5114,4166,4278,614-
Last Close Price
12.8214.4614.3818.8620.20-
PE Ratio
141.6066.8835.5766.1174.20-
PS Ratio
12.4313.739.4516.1516.70-
PB Ratio
2.372.652.663.654.06-
P/TBV Ratio
2.442.732.743.774.19-
P/FCF Ratio
---47.5687.71-
P/OCF Ratio
81.1363.7345.7033.1672.80-
EV/Sales Ratio
8.7910.126.6612.4815.93-
EV/EBITDA Ratio
145.4684.0326.6667.1462.68-
EV/EBIT Ratio
-152.2030.3785.2972.96-
EV/FCF Ratio
-175.20--36.7683.70-
Debt / Equity Ratio
0.000.000.000.00--
Debt / EBITDA Ratio
0.120.090.040.08--
Debt / FCF Ratio
---0.04--
Net Debt / Equity Ratio
-0.69-0.71-0.77-0.86-0.84-0.49
Net Debt / EBITDA Ratio
-63.60-30.39-10.97-20.42-13.53-1.58
Net Debt / FCF Ratio
72.5223.8736.73-11.18-18.07-3.19
Asset Turnover
0.180.180.260.210.350.77
Inventory Turnover
2.442.042.763.623.202.86
Quick Ratio
12.7910.4410.8610.0119.654.66
Current Ratio
13.9511.4011.9810.6620.676.09
Return on Equity (ROE)
1.66%3.92%7.60%5.59%8.32%28.28%
Return on Assets (ROA)
-0.06%0.74%3.60%1.95%4.71%16.15%
Return on Invested Capital (ROIC)
-0.30%4.44%29.32%18.58%28.75%67.67%
Return on Capital Employed (ROCE)
-0.10%1.30%6.10%3.30%5.30%28.40%
Earnings Yield
0.71%1.49%2.81%1.51%1.35%-
FCF Yield
-0.40%-1.12%-0.79%2.10%1.14%-
Dividend Yield
1.34%1.19%2.30%1.22%0.85%-
Payout Ratio
190.38%151.00%54.51%57.24%--
Buyback Yield / Dilution
-0.56%0.91%-0.97%-33.19%1.01%-0.90%
Total Shareholder Return
0.78%2.10%1.33%-31.97%1.86%-0.90%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.